Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Medicure (MCUJF) over the last 13 years, with Q3 2025 value amounting to $25425.9.

  • Medicure's Share-based Compensation fell 2117.06% to $25425.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $109390.4, marking a year-over-year decrease of 3240.39%. This contributed to the annual value of $140306.4 for FY2024, which is 3367.57% down from last year.
  • Medicure's Share-based Compensation amounted to $25425.9 in Q3 2025, which was down 2117.06% from $21651.4 recorded in Q2 2025.
  • In the past 5 years, Medicure's Share-based Compensation registered a high of $68319.2 during Q3 2021, and its lowest value of -$40460.1 during Q4 2021.
  • Over the past 5 years, Medicure's median Share-based Compensation value was $37224.2 (recorded in 2024), while the average stood at $34627.1.
  • Per our database at Business Quant, Medicure's Share-based Compensation tumbled by 16762.49% in 2021 and then surged by 17006.11% in 2023.
  • Over the past 5 years, Medicure's Share-based Compensation (Quarter) stood at -$40460.1 in 2021, then soared by 194.75% to $38337.3 in 2022, then soared by 45.61% to $55824.7 in 2023, then tumbled by 33.32% to $37224.2 in 2024, then crashed by 31.7% to $25425.9 in 2025.
  • Its Share-based Compensation stands at $25425.9 for Q3 2025, versus $21651.4 for Q2 2025 and $25089.0 for Q1 2025.